Literature DB >> 30194728

Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France.

Alice Kieny1, Bernard Cribier1, Nicolas Meyer2, Michel Velten3, Jérémie Jégu3,4, Dan Lipsker1.   

Abstract

Merkel Cell Carcinoma (MCC) is an aggressive skin cancer with an increasing incidence. Population-based epidemiologic data about MCC in France are rare. Our study aims to describe the epidemiology of MCC in Bas-Rhin, Northeastern of France, between 1985 and 2013. Data were collected from the Bas-Rhin Cancer Registry. We measured age-adjusted incidence rates (per 100,000 person-years) and effect of age, sex and period of diagnosis on survival. The world age-standardized incidence rate was 0.17 and it quadrupled between 1985 and 2013. Cases (n = 111) occurred mostly in women (60%) and in persons ≥70 years of age (74%). Incidence rates was close for men (0.18) and women (0.16) and was 25-time higher in people ≥70 years of age but incidence rate similarly increased between 1985 and 2013 in persons older and younger than 70 years. Net 5-year survival was 48.5%; female sex and younger age were positive predictors of survival. Given the low number of cases, incidence and survival data should be interpreted with caution. Incidence of MCC in Bas-Rhin quadrupled between 1985 and 2013. The highest incidence rate was observed in people ≥70 years. Better survival was associated with female sex and younger age. We hypothesize that MCC will still increase and be diagnosed in increasingly younger patients in next generations.
© 2018 UICC.

Entities:  

Keywords:  Merkel Cell Carcinoma; cancer registry; epidemiology

Mesh:

Year:  2018        PMID: 30194728     DOI: 10.1002/ijc.31860

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma.

Authors:  Shayan Cheraghlou; George O Agogo; Michael Girardi
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

Review 2.  Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor response.

Authors:  J S Hooiveld-Noeken; R S N Fehrmann; E G E de Vries; M Jalving
Journal:  Immunooncol Technol       Date:  2019-11-27

3.  Gender and immunosuppression impact on Merkel cell carcinoma diagnosis and prognosis. A population based cohort study.

Authors:  E Keeling; E O'Leary; S Deady; J P O Neill; P J Conlon; F J Moloney
Journal:  Skin Health Dis       Date:  2021-12-08

4.  Decreased IgG Antibody Response to Viral Protein Mimotopes of Oncogenic Merkel Cell Polyomavirus in Sera From Healthy Elderly Subjects.

Authors:  Chiara Mazziotta; Carmen Lanzillotti; Marcello Govoni; Giulia Pellielo; Elisa Mazzoni; Mauro Tognon; Fernanda Martini; John Charles Rotondo
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

5.  Avelumab as an Emerging Therapy for Eyelid and Periocular Merkel Cell Carcinoma.

Authors:  Giancarlo A Garcia; Andrea L Kossler
Journal:  Int Ophthalmol Clin       Date:  2020

Review 6.  Merkel Cell Carcinoma.

Authors:  Elena Dellambra; Maria Luigia Carbone; Francesca Ricci; Francesco Ricci; Francesca Romana Di Pietro; Gaia Moretta; Sofia Verkoskaia; Elisa Feudi; Cristina M Failla; Damiano Abeni; Luca Fania
Journal:  Biomedicines       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.